These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 34121201)

  • 1. ATP and cancer immunosurveillance.
    Kepp O; Bezu L; Yamazaki T; Di Virgilio F; Smyth MJ; Kroemer G; Galluzzi L
    EMBO J; 2021 Jul; 40(13):e108130. PubMed ID: 34121201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purinergic Signaling Within the Tumor Microenvironment.
    Draganov D; Lee PP
    Adv Exp Med Biol; 2021; 1270():73-87. PubMed ID: 33123994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
    De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
    Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
    Chiarella AM; Ryu YK; Manji GA; Rustgi AK
    Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X receptors in cancer growth and progression.
    Di Virgilio F; Vultaggio-Poma V; Sarti AC
    Biochem Pharmacol; 2021 May; 187():114350. PubMed ID: 33253643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints.
    Baghbani E; Noorolyai S; Shanehbandi D; Mokhtarzadeh A; Aghebati-Maleki L; Shahgoli VK; Brunetti O; Rahmani S; Shadbad MA; Baghbanzadeh A; Silvestris N; Baradaran B
    Life Sci; 2021 Oct; 282():119826. PubMed ID: 34265363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
    Dwyer KM; Kishore BK; Robson SC
    Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular ATP signaling and clinical relevance.
    Dou L; Chen YF; Cowan PJ; Chen XP
    Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and Function of Non-cell-bound CD73 in Inflammation.
    Schneider E; Rissiek A; Winzer R; Puig B; Rissiek B; Haag F; Mittrücker HW; Magnus T; Tolosa E
    Front Immunol; 2019; 10():1729. PubMed ID: 31404305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP and adenosine: Role in the immunopathogenesis of rheumatoid arthritis.
    da Silva JLG; Passos DF; Bernardes VM; Leal DBR
    Immunol Lett; 2019 Oct; 214():55-64. PubMed ID: 31479688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X7 is a cytotoxic receptor….maybe not: implications for cancer.
    Di Virgilio F
    Purinergic Signal; 2021 Mar; 17(1):55-61. PubMed ID: 33011962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular CD39/ENTPD1 directly promotes tumor cell growth by scavenging extracellular adenosine triphosphate.
    Feng L; Sun X; Csizmadia E; Han L; Bian S; Murakami T; Wang X; Robson SC; Wu Y
    Neoplasia; 2011 Mar; 13(3):206-16. PubMed ID: 21390184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity.
    Kashyap AS; Thelemann T; Klar R; Kallert SM; Festag J; Buchi M; Hinterwimmer L; Schell M; Michel S; Jaschinski F; Zippelius A
    J Immunother Cancer; 2019 Mar; 7(1):67. PubMed ID: 30871609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular ATP and adenosine: The Yin and Yang in immune responses?
    Faas MM; Sáez T; de Vos P
    Mol Aspects Med; 2017 Jun; 55():9-19. PubMed ID: 28093236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review].
    Wang C; Yin Q; Su Z; Xia L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Dec; 36(12):1134-1140. PubMed ID: 33325366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD73 and adenosine generation in the creation of regulatory microenvironments.
    Regateiro FS; Cobbold SP; Waldmann H
    Clin Exp Immunol; 2013 Jan; 171(1):1-7. PubMed ID: 23199317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain.
    Yegutkin GG; Boison D
    Pharmacol Rev; 2022 Jul; 74(3):797-822. PubMed ID: 35738682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles in cancer immune responses: roles of purinergic receptors.
    Graner MW
    Semin Immunopathol; 2018 Sep; 40(5):465-475. PubMed ID: 30209547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer.
    Schmid S; Kübler M; Korcan Ayata C; Lazar Z; Haager B; Hoßfeld M; Meyer A; Cicko S; Elze M; Wiesemann S; Zissel G; Passlick B; Idzko M
    Lung Cancer; 2015 Dec; 90(3):516-21. PubMed ID: 26505137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.